Your browser doesn't support javascript.
loading
Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing.
Sayegh, Souraya; Fantecelle, Carlos Henrique; Laphanuwat, Phatthamon; Subramanian, Priya; Rustin, Malcom H A; Gomes, Daniel C O; Akbar, Arne N; Chambers, Emma S.
  • Sayegh S; Division of Medicine, University College London, London, UK.
  • Fantecelle CH; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitoria, Brazil.
  • Laphanuwat P; Division of Medicine, University College London, London, UK.
  • Subramanian P; Division of Medicine, University College London, London, UK.
  • Rustin MHA; Department of Dermatology, Royal Free Hospital, London, UK.
  • Gomes DCO; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitoria, Brazil.
  • Akbar AN; Division of Medicine, University College London, London, UK.
  • Chambers ES; Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK.
Aging Cell ; 23(4): e14093, 2024 04.
Article en En | MEDLINE | ID: mdl-38287646
ABSTRACT
Vitamin D3 replacement in older insufficient adults significantly improves their antigen-specific varicella zoster virus (VZV) cutaneous immunity. However, the mechanisms involved in this enhancement of cutaneous immunity are not known. Here, we show for the first time that vitamin D3 blocks the senescence-associated secretory phenotype (SASP) production by senescent fibroblasts by partially inhibiting the p38 MAPK pathway. Furthermore, transcriptomic analysis of skin biopsies from older subjects after vitamin D3 supplementation shows that vitamin D3 inhibits the same inflammatory pathways in response to saline as the specific p38 inhibitor, losmapimod, which also enhances immunity in the skin of older subjects. Vitamin D3 supplementation therefore may enhance immunity during ageing in part by blocking p38 MAPK signalling and in turn inhibit SASP production from senescent cells in vivo.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Senescencia Celular / Colecalciferol Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Senescencia Celular / Colecalciferol Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Humans Idioma: En Año: 2024 Tipo del documento: Article